Sihai network

Four vaccine volunteers returned home after isolation, and their physical condition was normal

Four of the first batch of volunteers vaccinated with the new crown vaccine ended isolation and went home, 'everything is normal'

On March 31, the first four volunteers who received the recombinant new crown vaccine on the evening of March 16 ended their isolation observation and returned home. Before leaving Wuhan special service sanatorium, four volunteers took blood again as planned.

Jin Guanping, a volunteer who has finished isolation observation, told surging news that she took blood on March 24, the seventh day after vaccination. On the morning of March 31, the 14th day after vaccination, she took another blood collection. During the centralized isolation, her physical condition was normal.

Xiang Yafei, a volunteer vaccinated on March 19, is still under centralized isolation and observation in Wuhan special service sanatorium. He said: 'in the first three days of vaccination, my temperature was about 37.6 ℃ every night, with a low fever. Medical staff say this is a normal phenomenon, because the body's immune system is in contact with the vaccine & lsquo; Struggle & rsquo;. On the fourth night, the symptoms of low fever disappeared. Now, my body is normal. "

Surging news previously reported that since arriving in Wuhan on January 26, the scientific research team led by Chen Wei, academician of the Chinese Academy of engineering and researcher of the Academy of military medicine of the Chinese Academy of Military Sciences, has focused on emergency scientific research on vaccine development. On March 16, the recombinant new crown vaccine developed by academician Chen Wei's team passed the clinical research registration review; At 20:18 on the same day, it was approved to officially enter the clinical trial.

The reorganized novel coronavirus pneumonia vaccine (adenovirus vector) clinical research recruitment notice (hereinafter referred to as the "notice") shows that recombinant New Coronavirus vaccine (adenovirus vector) clinical research is recruiting volunteers to participate in the conditions, including the healthy adults with age range from 18 to 60 years old, no history of new crown pneumonia or infection history, no history of allergy to vaccination, and so on. The results of the study are as follows: (1) the New Coronavirus vaccine (adenovirus vector) clinical research recruitment notice.

According to the notice, 108 qualified volunteers will be recruited and divided into three research groups, namely low-dose vaccine group, medium dose vaccine group and high-dose vaccine group, with 36 people in each group.

According to the notice, after vaccination, volunteers will observe and recuperate in Wuhan special service convalescent center of East Lake for 14 days. In addition, the researchers will collect seven blood samples from each volunteer, mainly for antibody testing, within 7 days before vaccination, on the day of vaccination and on the 7th, 14th, 28th, 3rd and 6th months after vaccination. Each volunteer took 145 ml of blood.

Jin Guanping signed up on March 16. After passing the physical examination, she was vaccinated that night and became the first female volunteer. Three male volunteers were vaccinated with Jin Guanping.

On March 17, the first four volunteers were arranged to live in Wuhan special service sanatorium for centralized isolation and observation. Since then, other volunteers have entered the center for centralized isolation and observation after vaccination.